Brief: Bergenbio Q1 Operating Loss Narrows To NOK 72.4 Mln

Oncoinvent ASA

22/06/2023 08:40

June 22 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * TOTAL OPERATING EXPENSES FOR Q1 WERE NOK 72.4 MILLION (NOK
78.6
MILLION)
    * OPERATING LOSS FOR QUARTER CAME TO NOK 72.4 MILLION (NOK
78.6
MILLION) - CA
    * CASH AND CASH EQUIVALENTS AMOUNTED TO NOK 73.0 MILLION AT
END OF
MARCH 2023 (NOK 150.8 MILLION BY END OF DECEMBER 2022)

Source text for Eikon:  ID:nObiq6GbJa 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))